243 related articles for article (PubMed ID: 7523572)
1. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues.
Chen W; Khilko S; Fecondo J; Margulies DH; McCluskey J
J Exp Med; 1994 Oct; 180(4):1471-83. PubMed ID: 7523572
[TBL] [Abstract][Full Text] [Related]
2. The structural influence of individual residues located within peptide antigen depends upon their sequence context.
Chen W; Fecondo J; McCluskey J
Mol Immunol; 1994 Oct; 31(14):1069-75. PubMed ID: 7935498
[TBL] [Abstract][Full Text] [Related]
3. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
[TBL] [Abstract][Full Text] [Related]
4. Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides.
Mo AX; van Lelyveld SF; Craiu A; Rock KL
J Immunol; 2000 Apr; 164(8):4003-10. PubMed ID: 10754291
[TBL] [Abstract][Full Text] [Related]
5. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant.
Nikolić-Zugić J; Carbone FR
Eur J Immunol; 1990 Nov; 20(11):2431-7. PubMed ID: 2253683
[TBL] [Abstract][Full Text] [Related]
6. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif.
Lipford GB; Hoffman M; Wagner H; Heeg K
J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422
[TBL] [Abstract][Full Text] [Related]
7. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo.
Ma H; Kapp JA
Cell Immunol; 2001 Nov; 214(1):89-96. PubMed ID: 11902833
[TBL] [Abstract][Full Text] [Related]
8. Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant.
Kelly JM; Sterry SJ; Cose S; Turner SJ; Fecondo J; Rodda S; Fink PJ; Carbone FR
Eur J Immunol; 1993 Dec; 23(12):3318-26. PubMed ID: 8258346
[TBL] [Abstract][Full Text] [Related]
9. Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen.
Chen W; Carbone FR; McCluskey J
J Immunol Methods; 1993 Mar; 160(1):49-57. PubMed ID: 7680698
[TBL] [Abstract][Full Text] [Related]
10. Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs.
Jameson SC; Bevan MJ
Eur J Immunol; 1992 Oct; 22(10):2663-7. PubMed ID: 1396971
[TBL] [Abstract][Full Text] [Related]
11. Can one predict antigenic peptides for MHC class I-restricted cytotoxic T lymphocytes useful for vaccination?
Calin-Laurens V; Trescol-Biémont MC; Gerlier D; Rabourdin-Combe C
Vaccine; 1993; 11(9):974-8. PubMed ID: 7692684
[TBL] [Abstract][Full Text] [Related]
12. Differential binding of a minor histocompatibility antigen peptide to H-2 class I molecules correlates with immune responsiveness.
Wettstein PJ; van Bleek GM; Nathenson SG
J Immunol; 1993 Apr; 150(7):2753-60. PubMed ID: 7681080
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove.
Fremont DH; Stura EA; Matsumura M; Peterson PA; Wilson IA
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2479-83. PubMed ID: 7708669
[TBL] [Abstract][Full Text] [Related]
14. Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries.
Udaka K; Wiesmüller KH; Kienle S; Jung G; Walden P
J Exp Med; 1995 Jun; 181(6):2097-108. PubMed ID: 7539039
[TBL] [Abstract][Full Text] [Related]
15. In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability.
Lipford GB; Bauer S; Wagner H; Heeg K
Vaccine; 1995 Feb; 13(3):313-20. PubMed ID: 7631520
[TBL] [Abstract][Full Text] [Related]
16. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules.
Niedermann G; Butz S; Ihlenfeldt HG; Grimm R; Lucchiari M; Hoschützky H; Jung G; Maier B; Eichmann K
Immunity; 1995 Mar; 2(3):289-99. PubMed ID: 7535183
[TBL] [Abstract][Full Text] [Related]
17. Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and acidic pH.
Chefalo PJ; Harding CV
J Immunol; 2001 Aug; 167(3):1274-82. PubMed ID: 11466343
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis.
Reis e Sousa C; Germain RN
J Exp Med; 1995 Sep; 182(3):841-51. PubMed ID: 7650490
[TBL] [Abstract][Full Text] [Related]
19. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
[TBL] [Abstract][Full Text] [Related]
20. Production of a specific major histocompatibility complex class I-restricted epitope by ubiquitin-dependent degradation of modified ovalbumin in lymphocyte lysate.
Ben-Shahar S; Cassouto B; Novak L; Porgador A; Reiss Y
J Biol Chem; 1997 Aug; 272(34):21060-6. PubMed ID: 9261108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
